Results 21 to 30 of about 653,483 (216)
Joint UK societies' 2014 consensus statement on renal denervation for resistant hypertension. [PDF]
, 2014 Resistant hypertension continues to pose a major challenge to clinicians worldwide and has serious implications for patients who are at increased risk of cardiovascular morbidity and mortality with this diagnosis.
Matson, M +31 more
core +1 more source
The carotid body as a putative therapeutic target for the treatment of neurogenic hypertension [PDF]
, 2013 In the spontaneously hypertensive (SH) rat, hyperoxic inactivation of the carotid body (CB) produces a rapid and pronounced fall in both arterial pressure and renal sympathetic nerve activity (RSA).
Hendy, Emma B +8 more
core +1 more source
Renal Denervation for Resistant Hypertension [PDF]
Journal of Vascular Surgery, 2017 Resistant hypertension is highly prevalent among the general hypertensive population and the clinical management of this condition remains problematic. Different approaches, including a more intensified antihypertensive therapy, lifestyle modifications, or both, have largely failed to improve patients' outcomes and to reduce cardiovascular and renal ...
Coppolino G +3 more
openaire +3 more sources
Renal Denervation for Resistant Hypertension [PDF]
Progress in Cardiovascular Diseases, 2016 Renal denervation as a treatment for hypertension (HTN) has been shown to be effective as a surgical procedure. Over the past 10 years, an endovascular approach to replicate the results of surgical splanchnicectomy has been investigated to replace this surgical procedure with a less invasive procedure with lower morbidity.
Reilly, John P., White, Christopher J.
openaire +4 more sources
Quality of life following renal sympathetic denervation in treatment-resistant hypertensive patients: a two-year follow-up study [PDF]
, 2022 Objective. Hypertension is a significant health burden. In the last 10 years, renal sympathetic denervation has been tested as a potential treatment option for a select group of patients with treatmentresistant hypertension.
Hanssen, Tove Aminda +9 more
core +1 more source
Hypertension, 2020 The Asia Renal Denervation Consortium consensus conference of Asian physicians actively performing renal denervation (RDN) was recently convened to share up-to-date information and regional perspectives, with the goal of consensus on RDN in Asia. First- and second-generation trials of RDN have demonstrated the efficacy and safety of this treatment ...
Kario, Kazuomi +10 more
openaire +3 more sources
Renal sympathetic denervation for resistant hypertension: where do we stand after more than a decade
Brazilian Journal of Nephrology, 2020 Despite the current availability of safe and efficient drugs for treating hypertension, a substantial number of patients are drug-resistant hypertensives.
Marco Antônio Peliky Fontes +3 more
doaj +2 more sources
Graduate Medical Education Research Journal, 2019 Mentor: Irving H. Zucker Program: Anesthesiology Background & Objectives: The sympathetic nervous system is a master regulator of homeostasis, and sympathetic dysfunction is implicated in the pathophysiology of cardiovascular, renal, and neurological ...
Peter Ricci Pellegrino +4 more
doaj +1 more source
, 2020 El artículo ha sido comentado muy positivamente en "Persu A, Maes F, Renkin J, Pathak A. Renal Denervation in Hypertensive Patients: Back to Anatomy? Hypertension. 2020 Oct;76(4):1084-1086. doi: 10.1161/HYPERTENSIONAHA.120.15834. Epub 2020 Sep 9.
Maranillo Alcaide, Eva +3 more
core +1 more source
Lessons Learned from RADIOSOUND-HTN: Different Technologies and Techniques for Catheter-based Renal Denervation and Their Effect on Blood Pressure [PDF]
, 2019 The interest in renal denervation (RDN) as a treatment for arterial hypertension has returned with three proof of principle trials that have shown recently RDN to be superior to sham treatment.
Philipp Lurz, Karl Fengler
core +1 more source